Tesla and Curevac have developed a vaccine printer

Already in June 2019 the German biotech company Curevac and Tesla subsidiary Grohmann have applied for a patent for a newly developed vaccination printer.

A newly developed mobile "RNA Printer" is able to produce over a hundred thousand vaccination dosages in a few weeks. Originally developed to combat diseases like rabies and yellow fever it could potentially be used to produce a future Covid-19 vaccine given the approval for medical use of the printer and a vaccine.

co-founder of Pendect. Trying to protect free speech and democracies by creating a global news platform that is built through expert contribution. In love with vinyl, psytrance and penguins.
Card reviewed by: @ericof